CD4+ T-cell receptor recognizing H5 influenza hemagglutinin peptides (H5-specific CD4+ TCR)

CD4+ T-cell receptors (TCRs) recognizing H5-derived peptides presented on MHC class II are critical components of the adaptive immune system's defense against highly pathogenic avian influenza (HPAI) H5N1 (PubMed: 23536663). These receptors, typically composed of alpha and beta polypeptide chains, specifically bind to peptide fragments derived from the H5 hemagglutinin protein when they are displayed by Major Histocompatibility Complex (MHC) class II molecules on the surface of professional antigen-presenting cells (PubMed: 21148345). This recognition event is the primary signal for the activation of CD4+ helper T cells, which subsequently orchestrate the immune response by secreting cytokines like IFN-gamma and IL-2, and by providing essential signals for B-cell maturation and antibody production (PubMed: 19494211). In the context of H5N1 infection or vaccination, the breadth and specificity of the TCR repertoire for these H5 epitopes determine the effectiveness of the cellular immune response (PubMed: 25122781). Understanding these TCR-peptide-MHC interactions is vital for the development of universal influenza vaccines and immunotherapies aimed at enhancing cross-reactive immunity against emerging pandemic threats (PubMed: 28834710). While these TCRs are essential for protection, their over-activation can contribute to the "cytokine storm" observed in severe H5N1 cases, highlighting a delicate balance in therapeutic modulation (PubMed: 16604156).

Other names

H5-specific T-cell receptorHemagglutinin H5-specific TCRMHC class II-restricted H5-specific TCRAvian influenza H5-specific CD4+ TCR

The TCR recognizes specific H5-derived peptide fragments bound within the groove of MHC class II molecules on antigen-presenting cells, triggering a signaling cascade that leads to T-cell proliferation and the secretion of cytokines to coordinate the adaptive immune response (PubMed: 21148345).